Eli Lilly Has Its Mojo Back Ahead of A Pivotal Year for the Obesity Drug Giant

Sources: Alonso back to Mets for 2 years, $54M

Slugger Pete Alonso and the Mets are in agreement on a two-year, $54 million contract, sources said, ending a lengthy free agency with a return engagement to the only team for which he has played.

ESPN - 8h

Ford beats earnings expectations but forecasts tougher year ahead

Ford Motor beat Wall Street's top- and bottom-line expectations for the fourth quarter but forecast a tougher year ahead for the company.

CNBC - 23h

Equinor scales back green push 7 years after dropping ‘oil’ from its name

Norwegian group to increase fossil fuel production and halve spending on green energy

Financial Times - 1d

Collins, Lankford back Gabbard for top Intel job ahead of committee vote

Politico - 2d

Kansas could finish out of the top-three in its league in back-to-back seasons for first time in 40-plus years

Kansas used to own the Big 12 with a higher standard than every other team in the nation, but Bill Self's program is struggling

CBS Sports - 4d

2025 NFL Draft: Eli Manning describes four things he's looking for in the next Giants QB

Manning is 'all-in' on helping New York find its next franchise signal-caller

CBS Sports - 5d

Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week.

CNBC - 5d

Americans split on using weight loss drugs to treat obesity: Survey

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a survey published Friday. The new Associated Press (AP)-NORC ...

The Hill - 5d

Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon

Oil company Natural Resources and medical-device maker Beta Bionics shrug off a down market to gain in their trading debuts.

MarketWatch - 5d

A pivotal budget for India

Also in this newsletter, media companies take OpenAI to court and the tragedy at the Kumbh Mela

Financial Times - 6d

Oil giant Shell raises dividend despite full-year profit miss

British oil giant Shell on Thursday reported a significant drop in annual profit following a year of lower crude prices.

CNBC - Jan. 30

The White House Pulled Back Its Spending Freeze

Also, Menendez was sentenced to 11 years in prison. Here’s the latest at the end of Wednesday.

The New York Times - Jan. 29

How the Mets and Pete Alonso might pivot back to one another

The only reason we’re having this conversation two weeks after the Mets' pivot is that Pete Alonso has not yet found a home with another team.

Yahoo Sports - Jan. 29

Trump rolls back effort to lower Medicare, Medicaid drug costs

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

MarketWatch - Jan. 25

In Trump's first week, FCC chair signals headaches ahead for media giants

The action by FCC Chairman Brendan Carr shines a spotlight on fears that President Trump will use his power to threaten media outlets that don't support him.

Los Angeles Times - Jan. 24

Novo Nordisk Shares Surge on New Obesity Drug Results

Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.

The Wall Street Journal - Jan. 24

Four Years After Its Disastrous Launch, Cyberpunk 2077 Has A Great Steam User Score

Over four years after its undeniably rocky launch, Cyberpunk 2077 's recent Steam reviews have reached the coveted "overwhelmingly positive" rating. Per Steam's user-review data , 95% of the ...

GameSpot - Jan. 24

China unleashes record short-term funds ahead of lunar new year

Authorities try to pre-empt holiday cash crunch but shy from cut to reserve requirement ratio

Financial Times - Jan. 24

The U.K. has new powers vs. tech giants. It’s probing Apple and Google.

The U.K. competition regulator on Thursday said it’s using new powers to investigate Apple and Google’s mobile ecosystems.

MarketWatch - Jan. 23

What's left on Giants' offseason needs list ahead of spring training?

Alex Pavlovic highlights positions the San Francisco Giants should look to upgrade with MLB spring training right around the corner.

Yahoo Sports - Jan. 22

AI-developed drug will be in trials by year-end, says Google’s Hassabis

Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or neurodegeneration areas

Financial Times - Jan. 21

Does a Strong Holiday Shopping Season Mean a Better Year Ahead?

Consumers spent more than expected over the holidays on clothes and electronics. But the retail economy is still a mixed bag.

The New York Times - Jan. 20

Singer-songwriter Betty Boo looks back: ‘I was very naive in the 90s. It was only years later I realised people were on loads of drugs’

The Doin’ the Do singer on navigating the wild 90s, writing for other artists, and why she stepped out of the limelight for 30 years. Born in 1970, Alison Clarkson, AKA Betty Boo, is a ...

The Guardian - Jan. 18

Eli Lilly Has Its Mojo Back Ahead of A Pivotal Year for the Obesity Drug Giant

Sources: Alonso back to Mets for 2 years, $54M

Ford beats earnings expectations but forecasts tougher year ahead

Equinor scales back green push 7 years after dropping ‘oil’ from its name

Collins, Lankford back Gabbard for top Intel job ahead of committee vote

Kansas could finish out of the top-three in its league in back-to-back seasons for first time in 40-plus years

2025 NFL Draft: Eli Manning describes four things he's looking for in the next Giants QB

Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

Americans split on using weight loss drugs to treat obesity: Survey

Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon

A pivotal budget for India

Oil giant Shell raises dividend despite full-year profit miss

The White House Pulled Back Its Spending Freeze

How the Mets and Pete Alonso might pivot back to one another

Trump rolls back effort to lower Medicare, Medicaid drug costs

In Trump's first week, FCC chair signals headaches ahead for media giants

Novo Nordisk Shares Surge on New Obesity Drug Results

Four Years After Its Disastrous Launch, Cyberpunk 2077 Has A Great Steam User Score

China unleashes record short-term funds ahead of lunar new year

The U.K. has new powers vs. tech giants. It’s probing Apple and Google.

What's left on Giants' offseason needs list ahead of spring training?

AI-developed drug will be in trials by year-end, says Google’s Hassabis

Does a Strong Holiday Shopping Season Mean a Better Year Ahead?

Singer-songwriter Betty Boo looks back: ‘I was very naive in the 90s. It was only years later I realised people were on loads of drugs’

Obesity drugs Ozempic and Wegovy included in US price-cut talks

Borderless AI secures $32 million to challenge HR software giants with its AI-powered platform

Stay or Go: Should Giants bring Tommy DeVito back for the 2025 season?

Eli Manning has a complicated case as first-ballot Hall of Famer

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill

An English Soccer Giant Is Being Targeted by Organized Crime. Now It’s Fighting Back.

Fury fight has to happen this year - Joshua

The Minish Cap Has 20 Years Of Zelda Wonder Packed Inside Its Tiny Levels

Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise

AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

Sources: Verlander, Giants agree to 1-year deal

Topics